Learning Outcome 4.FRS4.44
Outcome 4.FRS4.44: Know efficacy and safety of new antiviral drugs (HCV Direct Acting Antivirals – DAAs), and need for combinations to avoid drug resistance
Navigation
Level Definitions
Updated: 4 December 2020/ Responsible Officer: Wendy Dimond/ Page Contact: meu.medicalschool@anu.edu.au
